Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Bupropion-Induced Dystonia in a Patient with Parkinson’s Disease

Vegda M, Panda S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Asymmetric Periodic Leg Movements during Sleep after Unilateral Supratentorial Infarction: Two Legs with One Lesion

Yoo SW, Choi KE, Kim JS

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Focal Unilateral Palatal Myoclonus Causing Objective Clicking Tinnitus without Uvula Elevation Diagnosed by Concurrent Auscultation

Selvadurai C, Schaefer SM

Palatal myoclonus generally entails a visible elevation of the palate and uvula and may be accompanied by myoclonus of other oropharyngeal muscles. A 55-year-old man presented with left ear clicking...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Update on Current Technologies for Deep Brain Stimulation in Parkinson’s Disease

Paff M, Loh A, Sarica C, Lozano AM, Fasano A

Deep brain stimulation (DBS) is becoming increasingly central in the treatment of patients with Parkinson’s disease and other movement disorders. Recent developments in DBS lead and implantable pulse generator design...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-GABAB Receptor Encephalitis Presenting with Atypical Corticobasal Syndrome in a Patient with Parkinson’s Disease

Abdullah NS, Jan TH, Remli R, Mukari SAM, Ibrahim NM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis

Holla VV, Neeraja K, Surisetti BK, Prasad S, Kamble N, Srinivas D, Yadav R, Pal PK

Objective The novel coronavirus disease (COVID-19) pandemic and public health measures to control it have resulted in unique challenges in the management of patients with deep brain stimulation (DBS). We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A New Allelic Variant in the PANK2 Gene in a Patient with Incomplete HARP Syndrome

Martos ML, Reyes MJS, Iglesias RM, Moro CG, Gutiérrez ML, Pedregosa LE

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Young-Onset Parkinson’s Disease with Impulse Control Disorder Due to Novel Variants of F-Box Only Protein 7

Yoo D, Choi JH, Im JH, Kim MJ, Kim HJ, Park SS, Jeon B

F-box only protein 7 (FBXO7) is a rare monogenic cause of hereditary Parkinson’s disease (PD) with an autosomal recessive mode of inheritance and a broad spectrum of clinical manifestations. Here,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Syndrome in a Korean Family

Kim M, Oh SH, Cho JW, Lee JH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease

Park KW, Jo S, Lee SH, Hwang YS, Lee D, Ryu HS, Chung SJ

Objective To investigate the efficacy of levodopa/carbidopa/entacapone (LCE) at bedtime for treating sleep disturbance in patients with Parkinson’s disease (PD) with motor fluctuations. Methods Participants included 128 PD patients with motor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of Exercise on the Sequence Effect in Parkinson’s Disease

Kang SY, Sohn YH

Objective To determine the benefits of motor training on the sequence effect (SE), an essential component of bradykinesia in Parkinson’s disease (PD). Methods Seven patients with de novo PD participated in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Parkinson Anxiety Scale: A Validation Study for the Brazilian Population

Moraes-Ferreira R, Alves WMGdC, Brandao-Rangel MAR, Abrahin O, Pimentel CP, Correa-Sousa E, Vieira RP, Cortinhas-Alves EA

Objective The Parkinson Anxiety Scale (PAS) was developed to measure the severity of anxiety symptoms in patients with Parkinson’s disease (PD), and it has not yet been adapted and validated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emerging Concepts of Motor Reserve in Parkinson’s Disease

Chung SJ, Lee JJ, Lee PH, Sohn YH

The concept of cognitive reserve (CR) in Alzheimer’s disease (AD) explains the differences between individuals in their susceptibility to AD-related pathologies. An enhanced CR may lead to less cognitive deficits...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr